Navigation Links
Fujifilm's Exclusive Software Advances Cardiovascular Reporting Capabilities
Date:3/17/2011

STAMFORD, Conn., March 17, 2011 /PRNewswire/ -- ACC Booth # 2001 -- Further enhancing its cardiovascular reporting capabilities, FUJIFILM Medical Systems U.S.A., Inc. is pleased to announce the availability of its Intelligent Structured Reporting (ISR) technology. An advanced software decision support system, ISR will be featured along with the complete line-up of Synapse® Cardiovascular products at the American College of Cardiology (ACC) 2011 Annual Scientific Session and Expo April 2nd – 5th in New Orleans, La. Available exclusively from Fujifilm, ISR is the latest addition to the Synapse® family of integrated solutions dedicated to enhancing clinical workflow and increasing diagnostic certainty.

"The number of exams and associated workload for cardiologists and sonographers has been steadily increasing, so it's our mission to provide technologies that can enable them to be more efficient," says Jim Morgan, Vice President, Medical Informatics at Fujifilm. "Synapse Cardiovascular's Intelligent Structured Reporting is proven to increase productivity for clinicians, increase the quality of echocardiography reports generated, and increase the overall level of care for patients."

ISR Equals Increased Efficiency and High Quality

ISR increases user efficiency by enabling cardiologists to read more exams in less time. It does this by incorporating an advanced tool set that directly ties echo measurement data and clinical statements to a comparative knowledge base. This helps improve the reading accuracy and report consistency when interpreting echocardiograms. Advanced capabilities of ISR include the ability to monitor input echo measurements in real-time, warn the user of inconsistencies, and automatically complete an echocardiography report based on absolute and inferred data. The application also suggests further areas of evaluation based on clinical findings and outlines a treatment consideration for the patient.

A New Era in Clinical Reporting

ISR brings a new clinical concept to echo reporting using the Agile Computing Theory. This innovative technology makes frequent, real-time updates to Synapse Cardiovascular to ensure that the cardiologist and sonographers are equipped with the latest cardiovascular information. This data is standards based and all suggestions provided by the system are directly traceable to a clinical source. The database includes thousands of peer reviewed clinical papers so cardiologists have the ability to prove statements and perform further research.

In addition to the Synapse Cardiovascular ISR technology, Fujifilm will also be featuring its full range of informatics products including Synapse® 3D and Synapse® Mobility at the 2011 ACC.  For more information on these products visit booth number 2001 or log on to www.fujimed.com.

About Fujifilm

FUJIFILM Medical Systems U.S.A., Inc. is a leading provider of diagnostic imaging products and medical informatics solutions to meet the needs of healthcare facilities today and well into the future. From an unrivaled selection of digital x-ray systems, to the Synapse® brand of PACS, RIS and cardiovascular products, to advanced women's health imaging systems, Fujifilm has products that are ideal for any size imaging environment. FUJINON is a subsidiary of FUJIFILM Medical Systems U.S.A., Inc., and supplies technologically advanced endoscopes to the medical market. FUJIFILM Medical Systems U.S.A., Inc. is headquartered in Stamford, CT.  For more information visit www.fujimed.com.  

© 2011 FUJIFILM Medical Systems U.S.A., Inc.  


'/>"/>
SOURCE FUJIFILM Medical Systems U.S.A., Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. PDI Announces Exclusive Partnership With Qforma, Leading Provider of Advanced Analytics for Health Sciences Industry
2. Argon Medical Devices Announces Exclusive License and Distribution Agreement for Option™ Retrievable Inferior Vena Cava Filter
3. Prasco Announces Agreement with Shire for Future Exclusive Distribution and Supply of Authorized Generic for PENTASA®
4. Omeros Announces Expansion of Exclusive License to PDE7 Inhibitors from Daiichi Sankyo
5. Sheffield Bio-Science and Wockhardt Announce Worldwide Exclusive Partnership to Supply Recombinant Insulin to Cell Culture Market
6. Smith & Nephews Exclusive OXINIUM™ Material for Hip Replacement Implants Chosen for Premium Reimbursement in Japanese Market
7. Perrigo Enters Into Exclusive Sales and Distribution Agreement With AgaMatrix for Store Brand Blood Glucose Monitoring Products
8. OHK Medical Devices Selects Henry Schein as Exclusive Distributor of HemaClear®
9. Pfenex Inc. and Boehringer Ingelheim Announce Non-Exclusive Strategic Agreement for the Use of Pfenex Expression Technology™
10. BD and UCL Business Reach Exclusive License Agreement to Advance Development of New Diagnostic Tests for Ovarian and Breast Cancers
11. Soligenix Executes Exclusive License with the University of Colorado for Vaccine Thermostabilization Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... -- International Biophysics Corporation, a global medical device manufacturer based in ... revenue growth in 2016 when compared to the previous year ... was fueled by its AffloVest® sales in the ... its global sales of surgical product lines. Said ... our 25 th year in delivering high-quality, innovative medical ...
(Date:2/27/2017)... Calif. , Feb. 27, 2017   Vitasome ... line of nutritional supplements using its groundbreaking new liposome ... 90 percent of potency through digestion per Physician,s ... supplements solve the problem of nutritional waste and are ... degradation during digestive processes Improve bioavailability ...
(Date:2/27/2017)... Feb. 27, 2017  RegeneRx Biopharmaceuticals, Inc. (OTCQB: ... development company focused on tissue protection, repair and ... GtreeBNT Co., Ltd., received a positive response from ... trial design for RGN-137 to treat epidermolysis bullosa ... that incorporates Thymosin beta 4 ("Tß4") as the ...
Breaking Medicine Technology:
(Date:2/27/2017)... CA (PRWEB) , ... February 27, 2017 , ... ... muscle mass and overall body strength, which often leads to a host of ... Journal of the American Geriatrics Society discovered that good overall muscle ...
(Date:2/27/2017)... ... 27, 2017 , ... Much attention has been paid to the problem of ... opioid painkillers has fallen short. From 1999 until 2010, fatal overdoses from prescription pain ... overdoses in male populations.(1) , The proportion of women using illicit drugs is also ...
(Date:2/27/2017)... ... February 27, 2017 , ... ... on laser diffraction analysis as a tool to characterize particle size distributions in ... to obtain improved results and novel scientific findings. It describes methods of optimized ...
(Date:2/27/2017)... ... 27, 2017 , ... Sunshine Coast Health Centre (SCHC), one ... at https://www.sunshinecoasthealthcentre.ca/ , is proud to announce the addition of a registered ... Centre's commitment to innovation in drug rehab and alcohol treatment strategies beyond a ...
(Date:2/26/2017)... ... ... The February 13, 2017, assassination of Kim Jong-nam, the half brother of ... deadly use of chemical weapons. Many questions exist about the effect that nerve agents ... lethal. , Jay Jagannathan, M.D., of Michigan-based Jagannathan Neurosurgical Institute, and one of the ...
Breaking Medicine News(10 mins):